The Strongest Biotech Stock In The Market
For now, it seems as if the market has calmed down a bit.
The market over the last month saw the S&P 500 drop almost 10 percent from its high before finally finding its footing last Wednesday.
Most stocks got hit pretty hard during that drop, but some held up relatively well. Other stocks may have sold off with the overall market but then popped nicely once the selloff was over.
There have been stocks that have far outperformed the market since the Wednesday bottom.
For example, the S&P has rallied almost 4 percent since its low of 1,820 last week. However, there's one biotech stock that not only bottomed two days before the market did, but has also more than doubled since that bottom.
Take a look at the chart of Newlink Genetics Corp (NASDAQ: NLNK)
Even though the market bottomed last Wednesday, Newlink bottomed two days prior.
Once hitting the $17.50 mark, the stock hit an intraday high of almost $37; it was trading at $31.31 at time of publication.
The rally that Newlink has embarked on is the strongest price performance of all biotech stocks within the Newlink's general price and volume range.
Investors should conduct their own due diligence before investing in any stock, and after such a serious run it may be time for a cool off.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.